| Dr Gregory Scott Rosenblatt, MD | |
|
333 Se 7th Ave, Suite 4500, Hillsboro, OR 97123-4157 | |
| (503) 648-6611 | |
| Not Available |
| Full Name | Dr Gregory Scott Rosenblatt |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 23 Years |
| Location | 333 Se 7th Ave, Hillsboro, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972711703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | A98842 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tuality Community Hospital | Hillsboro, OR | Hospital |
| Ohsu Hospital And Clinics | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tuality Medical Group Llc | 7416173414 | 245 |
News Archive
Pulse, an industry-leading vendor of ambulatory healthcare software solutions has been named as one of the fastest-growing private companies in America.
Researchers from the University of California, San Diego School of Medicine and Naval Health Research Center have found that mindfulness training - a combination of meditation and body awareness exercises - can help U.S. Marine Corps personnel prepare for and recover from stressful combat situations.
People with kidney disease undergo balloon dilation treatment after myocardial infarction less frequently, and therefore have a poorer prognosis. This according to new clinical research published in the journal Circulation.
MEDRAD, INC., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocath technology.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 9 days ago
| Entity Name | Tuality Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
Pulse, an industry-leading vendor of ambulatory healthcare software solutions has been named as one of the fastest-growing private companies in America.
Researchers from the University of California, San Diego School of Medicine and Naval Health Research Center have found that mindfulness training - a combination of meditation and body awareness exercises - can help U.S. Marine Corps personnel prepare for and recover from stressful combat situations.
People with kidney disease undergo balloon dilation treatment after myocardial infarction less frequently, and therefore have a poorer prognosis. This according to new clinical research published in the journal Circulation.
MEDRAD, INC., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocath technology.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 9 days ago
| Entity Name | Tuality Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
Pulse, an industry-leading vendor of ambulatory healthcare software solutions has been named as one of the fastest-growing private companies in America.
Researchers from the University of California, San Diego School of Medicine and Naval Health Research Center have found that mindfulness training - a combination of meditation and body awareness exercises - can help U.S. Marine Corps personnel prepare for and recover from stressful combat situations.
People with kidney disease undergo balloon dilation treatment after myocardial infarction less frequently, and therefore have a poorer prognosis. This according to new clinical research published in the journal Circulation.
MEDRAD, INC., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocath technology.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Scott Rosenblatt, MD 333 Se 7th Ave, Suite 4500, Hillsboro, OR 97123-4157 Ph: (503) 648-6611 | Dr Gregory Scott Rosenblatt, MD 333 Se 7th Ave, Suite 4500, Hillsboro, OR 97123-4157 Ph: (503) 648-6611 |
News Archive
Pulse, an industry-leading vendor of ambulatory healthcare software solutions has been named as one of the fastest-growing private companies in America.
Researchers from the University of California, San Diego School of Medicine and Naval Health Research Center have found that mindfulness training - a combination of meditation and body awareness exercises - can help U.S. Marine Corps personnel prepare for and recover from stressful combat situations.
People with kidney disease undergo balloon dilation treatment after myocardial infarction less frequently, and therefore have a poorer prognosis. This according to new clinical research published in the journal Circulation.
MEDRAD, INC., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocath technology.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
› Verified 9 days ago
Dr. Sean Joseph Clark, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2875 Ne Stucki Ave, Hillsboro, OR 97124 Phone: 971-278-0688 | |
Dr. Ronald Im, M.D. Urology Medicare: Medicare Enrolled Practice Location: 2875 Nw Stucki Ave, Hillsboro, OR 97124 Phone: 971-310-3722 Fax: 971-310-3701 | |
Edith Alfredda Kahrhoff, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2875 Nw Stucki Avenue, Northwest Permanente Pc-westside Medical Specialities, Hillsboro, OR 97124 Phone: 971-310-3708 |